Expecto Health Science proudly participated in Swiss Biotech Day 2026 as part of the Singapore delegation supported by Enterprise Singapore. The event, held in Basel, brought together over 3,000 industry…
Partnership aims to improve cost-to-deliver, compress timelines, strengthen compliance, and enable faster, evidence-backed decision-making across the clinical development lifecycle Singapore, 09 April 2026 Expecto Health Science, a full-service Asia-Pacific Contract…
Expecto Health Science is pleased to be a part of the ISCR Conference 2026, one of the key gatherings for professionals and leaders in the clinical research industry. The conference…
Singapore, 19 February 2026 – Expecto Health Science, a Singapore-headquartered, Asia-focused clinical research organization (CRO), and Southern Star Research (SSR), a leading Australia-based CRO, today announced a strategic investment-driven partnership.…
The Expecto Health Science team attended the ASMA | Annual Summit on Medical Affairs 2025 in Singapore, engaging in insightful discussions on the future of Medical Affairs, AI and digital…
Expecto Health Science attended ESMO Asia 2025, gaining valuable insights into emerging oncology therapies and clinical research trends across the APAC region. The conference supported our ongoing commitment to advancing…
Expecto Health Science is pleased to announce that it has received the License to Operate as a Contract Research Organization (CRO) from the Philippines Food and Drug Administration (FDA). This…
We are pleased to share an important milestone for Expecto Health Science: achievement of First Patient In (FPI) in a global clinical study within five months of regulatory submission. This…
This collaboration brings together Ubuntu Research Inc’s deep expertise in translational science with Expecto Health Science robust capabilities in global clinical trial execution New Delhi: Expecto Health Science, a Singapore-based clinical…
